[On the treatment of chronic polyarthritis with cytostatic agents. I. Combined therapy with trenimon and proresid. Clinical and serological studies].
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011033:Podophyllin / Q000627:therapeutic use; D011035:Podophyllum / Q000627:therapeutic use*; D014228:Triaziquone / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011033:Podophyllin; D014228:Triaziquone
Zur Behandlung der chronischen Polyarthritis mit Zytostatika. I. Kombinationstherapie mit Trenimon und Proresid. Klinische und serologische Studien.